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Dear Editor,
The recruitment of hematopoietic stem cells (HSCs) to the ischemic brain plays a crucial role in functional recovery (Borlongan, 2011; Borlongan et al.a, 2011b; Toth et al., 2008) . Notably, Epac1 (exchange protein directly activated by cAMP-1) promotes integrin-mediated cell spreading on and adhesion to laminin-5 (Enserink et al., 2004) , and the adhesion of HSCs to endothelial monolayers and to the matrix protein fibronectin (Carmona et al., 2008) . Likewise, stimulation of Epac1 in cultured endothelial progenitor cells (EPCs) ex vivo prior to their exogenous intravenous injection promotes their recruitment to and neovascularization in the ischemic limb (Carmona et al., 2008) . These raise the intriguing possibility that Epac1 could play a role in HSC recruitment following stroke. In this study, we found increases in Epac1 in the ischemic brains from humans and rodents. This Epac1 expression was induced by the binding of hypoxia-inducible factor 1α (HIF-1α) to the Epac1 promoter, and was required for the matrix metalloprotease (MMP) mediated recruitment of HSCs.
The recruited HSCs contributed to neovascularization, leading to increased blood flow and functional recovery. Importantly, exogenous stimulation or overexpression of Epac1 markedly increased HSC recruitment, and promoted recovery in a rat model of cerebral ischemia.
In investigating Epac1 expression following stroke, we immunostained brain slices from patients who died from fatal ischemic stroke, and found substantial Epac1 immunoreactivity in the penumbra (Supplementary Figure S1A and Figure S1F and I-K). Consistent with Epac1 in mediating Rap1 signaling (de Rooij et al., 1998; Kawasaki et al., 1998) , the increase in Epac1 is accompanied by an increase in Rap1-GTP (Supplementary Figure S1G and H).
Next, we investigated whether HIF-1α participated in Epac1 upregulation. In mouse primary cortical cultures (PCCs; populated largely by neurons ( Figure 1A) ), hypoxia was sufficient for increasing Epac1 expression ( Figure 1B and C) and Rap1 activation ( Figure 1D ). While control PCCs expressed evenly-distributed HIF-1α and little Epac1 ( Figure 1E and G), hypoxia induced HIF-1α nuclear translocation ( Figure   1E ) and increased Epac1 expression ( Figure 1E and G). Both HIF-1α translocation and Epac1 expression required HIF-1α activity, because both were prevented by the HIF-1α inhibitor 2-ME2 (2-methoxyestradiol; Figure 1E -G), or by HIF-1α knockdown using lentiviral delivery of the shRNA for HIF-1α (LV-HIF-1α-shRNA) ( Figure 1G ). 2-ME2 was specific to HIF-1α-induced Epac1 expression, as it had no effect on lentiviral (LV-Epac1) infection-induced Epac1 expression ( Figure 1H ). Likewise in vivo, Figure 1K ).
Hypoxia increased luciferase activity in cells transfected with a HRE-containing
Epac1 promoter construct (pEpac1-luc1), but not in cells transfected with a HRElacking construct (pEpac1-luc2) or a HRE-mutant construct (pEpac1-mutHRE).
Taken together, hypoxia and ischemic stroke induced HIF-1α activation and nuclear translocation, where it binds to the HRE site on the Epac1 promoter to induce Epac1 upregulation ( Figure 1L ).
In support of the notion that Epac1 participates in HSC recruitment and Figure S6D) and LV-Epac1-shRNA increased (Supplementary Figure   S6E ) infarct volume in rats subjected to cerebral ischemia. Our present data demonstrate that treatments that stimulate/increase Epac1 can facilitate recovery from stroke by potentiating an endogenous self-protective mechanism, that is, neovascularization by recruiting HSCs in a MMP-dependent manner (Supplementary Figure S7) .
The Epac proteins are cAMP-dependent guanine nucleotide exchange factors (GEFs) for the small GTPases Rap1 (de Rooij et al., 1998; Kawasaki et al., 1998) and Rap2 (de Rooij et al., 2000) . They were known to regulate important cellular processes, including cell proliferation, cell survival, gene transcription, vesicle secretion, ion transport, calcium regulation, and neuronal signaling (Bos, 2006; Holz et al., 2006) , and their unique physiological (Bos, 2006; Carmona et al., 2008; Holz et al., 2006) and pathological (McPhee et al., 2005; Ulucan et al., 2007) roles suggest these proteins may 7 be novel therapeutic targets for disease intervention. The present study found that HIF-1α directly binds to the Epac1 promoter, and as such, promotes Epac1 protein expression. Therefore, Epac1 may be a downstream mediator for many known functions mediated by HIF-1α (Majmundar et al., 2010; Semenza, 2010 activity in nuclear extract of control PCCs and PCCs subjected to 4 h-hypoxia was measured by means of ELISA, and expressed as optical density (OD 450-540).
Nuclear extract was collected immediately post-hypoxia. This increase in nuclear HIF-1α activity was prevented by 2-ME2 (10 µM, pretreated for 16 h); n = 10 per group. (G) Western blot for Epac1 and nuclear HIF-1α expression in PCCs subjected to 4 h-hypoxia, and HIF-1α inhibition by 2-ME2 (10 µM, pretreated for 16 h) or HIF-
